A cross-sectional association between bone mineral density and parathyroid hormone and other biomarkers in community-dwelling young adults: The CARDIA study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages 4038-4046

  Fujiyoshi, Akira ^a   Polgreen, Lynda E ^b   Hurley, Daniel L ^d   Gross, Myron D ^b   Sidney, Stephen ^e   Jacobs Jr , David R ^c,f  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d MAYO CLINIC   (United States)

^e DIVISION OF RESEARCH   (United States)

^f UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; BONE SPECIFIC ALKALINE PHOSPHATASE; CREATININE; OSTEOCALCIN; PARATHYROID HORMONE; PYRIDINOLINE; UNCLASSIFIED DRUG;

ADULT; ARM; ARTICLE; BONE DENSITY; COMMUNITY LIVING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GENDER; HIP; HUMAN; HUMAN EXPERIMENT; LINEAR REGRESSION ANALYSIS; LUMBAR SPINE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES; URINALYSIS; WEIGHT BEARING;

ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; OSTEOCALCIN; PARATHYROID HORMONE; VITAMIN D;

EID: 84885211415     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-2198     Document Type: Article

References (44)

1. Dresner-Pollak R., Parker RA, Poku M, Thompson J., Seibel MJ, Greenspan SL Biochemical markers of bone turnover reflect femoral bone loss in elderly women. Calcif Tissue Int. 1996; 59: 328-333.
2. Delmas PD, Schlemmer A, Gineyts E., Riis B, Christiansen C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res. 1991; 6: 639-644.
3. Eastell R, Hannon RA Biomarkers of bone health and osteoporosis risk. Proc Nutr Soc. 2008; 67: 157-162.
4. Ross PD, Knowlton W. Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 1998; 13: 297-302.
5. Garnero P, Hausherr E, Chapuy M.C., et al Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. J Bone Miner Res. 1996; 11: 1531-1538.
6. Garnero P, Sornay-Rendu E, Claustrat B., Delmas PD Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. J Bone Miner Res. 2000; 15: 1526-1536.
7. Eriksen EF, Charles P, Melsen F., Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res. 1993; 8: 127-132.
8. Bischoff-Ferrari H.A., Dietrich T, Orav E.J., Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004; 116: 634-639
9. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-281.
10. Souberbielle JC, Lawson-Body E, Hammadi B., Sarfati E, Kahan A, Cormier C. The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. J Clin Endocrinol Metab. 2003; 88: 3501-3504.
11. Arabi A, Baddoura R, El-Rassi R, El-Hajj Fuleihan G. PTH level but not 25 (OH) vitamin D level predicts bone loss rates in the elderly. Osteoporos Int. 2012; 23(3): 971-980.
12. Curtis JR, Ewing SK, Bauer D.C., et al Association of intact parathyroid hormone levels with subsequent hip BMD Loss: the Osteo-porotic Fractures in Men (MrOS) Study. J Clin Endocrinol Metab. 2012; 97(6): 1937-1944.
13. Sahota O, Mundey MK, San P, Godber I.M., Lawson N., Hosking DJ. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in post-menopausal women with established osteoporosis. Bone. 2004; 35: 312-319.
14. Sowers MF, Hollis BW, Shapiro B, et al Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996; 276: 549-554.
15. Khaw KT, Sneyd MJ, Compston J. Bone density parathyroid hormone and 25-hydroxyvitamin D concentrations in middle aged women. BMJ. 1992; 305: 273-277.
16. Aloia JF, Feuerman M, Yeh JK Reference range for serum parathyroid hormone. Endocr Pract. 2006; 12: 137-144.
17. Friedman GD, Cutter GR, Donahue R.P., et al CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988; 41: 1105-1116.
18. Bikle DD, Ettinger B, Sidney S., Tekawa IS, Tolan K. Differences in calcium metabolism between black and white men and women. Miner Electrolyte Metab. 1999; 25: 178-184.
19. Ettinger B, Sidney S, Cummings S.R., et al Racial differences in bone density between young adult black and white subjects persist after adjustment for anthropometric, lifestyle, and biochemical differences. J Clin Endocrinol Metab. 1997; 82: 429-434.
20. Nussbaum SR, Zahradnik RJ, Lavigne J.R., et al Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987; 33: 1364-1367.
21. Taylor AK, Linkhart SG, Mohan S, Baylink DJ Development of a new radioimmunoassay for human osteocalcin: evidence for a midmolecule epitope. Metabolism. 1988; 37: 872-877.
22. Farley JR, Chesnut CH 3rd, Baylink DJ. Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin. Clin Chem. 1981; 27: 2002-2007.
23. Seyedin SM, Kung VT, Daniloff Y.N., et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res. 1993; 8: 635-641.
24. Black D, Duncan A, Robins SP Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reversed-phase high-performance liquid chromatography. Anal Biochem. 1988; 169: 197-203.
25. Liu K, Slattery M, Jacobs D Jr, et al A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis. 1994; 4: 15-27.
26. Jacobs DR J.r., Hahn LP, Haskell W.L., Pirie P., Sidney S. Validity and Reliability of Short Physical Activity History: Cardia and the Minnesota Heart Health Program. J Cardiopulmonary Rehabil. 1989; 9: 448-459.
27. Steingrimsdottir L, Gunnarsson O, Indridason O.S., Franzson L., Sigurdsson G. Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA. 2005; 294: 2336-2341.
28. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levelisassociated with body mass index. The 5th Tromsø study. Eur J Endocrinol. 2004; 151: 167-172.
29. Blind E, Schmidt-Gayk H, Scharla S., et al Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathy-roidism and other disorders of calcium metabolism compared with a midregion assay. J Clin Endocrinol Metab. 1988; 67: 353-360.
30. Endres DB, Villanueva R, Sharp CF Jr, Singer FR Immunochemi-luminometric and immunoradiometric determinations of intact and total immunoreactive parathyrin: performance in the differential diagnosis of hypercalcemia and hypoparathyroidism. Clin Chem. 1991; 37: 162-168.
31. Hall JE. Renal Regulation of potassium, calcium, phosphate, and magnesium; integration of renal mechanisms for control of blood volume and extracellular fluid volume (chapter 29). In: Guyton and Hall Textbook of Medical Physiology. 12th ed. Philadelphia, PA: Elsevier; 2011. pp. 367-368.
32. Arya V, Bhambri R, Godbole M.M., Mithal A. Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int. 2004; 15: 56-61.
33. Rogers A, Hannon RA, Eastell R. Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res. 2000; 15: 1398-1404.
34. Riggs BL, Wahner HW, Melton LJ 3rd, Richelson LS, Judd HL, Offord KP. Rates of bone loss in the appendicular and axial skeletons of women. Evidence of substantial vertebral bone loss before menopause. J Clin Invest. 1986; 77: 1487-1491.
35. Rubin MR, Bilezikian JP, McMahon D.J., et al The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab. 2008; 93: 3462-3470.
36. Peacock M, Buckwalter KA, Persohn S, Hangartner T.N., Econs MJ, Hui S. Race and sex differences in bone mineral density and geometry at the femur. Bone. 2009; 45: 218-225.
37. Gutiérrez O.M., Farwell WR, Kermah D, Taylor EN Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int. 2011; 22: 1745-1753.
38. Dawson-Hughes B, Lindsay R, Khosla S, et al, eds. Clinician's Guide to Prevention and Treatment for Osteoporosis. Washington, DC: National Osteoporosis Foundation; 2010.
39. Watts NB, Bilezikian JP, Camacho P.M., et al American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract. 2010; 16(SUPPL. 3):1-37.
40. U.S. Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med. 2011; 154: 356-364.
41. Davies JH, Evans BA, Gregory JW Bone mass acquisition in healthy children. Arch Dis Child. 2005; 90: 373-378.
42. Recker RR, Davies KM, Hinders S.M., Heaney RP, Stegman MR, Kimmel DB Bone gain in young adult women. JAMA. 1992; 268: 2403-2408.
43. Ralston SH. The genetics of osteoporosis. QJM. 1997; 90: 247-251.
44. Orwoll ES, Bell NH, Nanes M.S., Flessland KA, Pettinger MB, Mallinak NJ, Cain DF Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability. J Clin Endocrinol Metab. 1998; 83: 3930-3935.